Sanofi-Aventis Voluntarily Pauses Ketek Pediatric Trials Pending FDA Consultation
The decision to stop pediatric studies of the antibiotic was not at FDA’s request or due to safety concerns, the company says.
The decision to stop pediatric studies of the antibiotic was not at FDA’s request or due to safety concerns, the company says.